MSB 3.77% $1.52 mesoblast limited

Thanks for sharing@Wilba32I think it important to also reference...

  1. 563 Posts.
    lightbulb Created with Sketch. 219
    Thanks for sharing@Wilba32

    I think it important to also reference Dr Lightner's response to Dr Cheng's letter to the editor re the important role of anti-TNF in treating refractory pCD, suggesting a contributing role of MSCs....

    From Dr Lightner's reply
    "however, by definition, the patients enrolled were refractory to anti-TNF, and their fistulas had not healed despite being on medical therapy. In fact, all patients enrolled had either failed medical therapy or were on stable medical therapy for at least 3 months before study enrollment to minimize any
    confounding with MSC healing."

    Good signs but more work to do

    DYOR

    V




    Reference:
    https://hotcopper.com.au/data/attachments/6130/6130813-fffc85b353415c0e2be642c8ba462686.jpg

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.52
Change
0.055(3.77%)
Mkt cap ! $1.729B
Open High Low Value Volume
$1.48 $1.54 $1.45 $6.072M 4.049M

Buyers (Bids)

No. Vol. Price($)
1 5951 $1.52
 

Sellers (Offers)

Price($) Vol. No.
$1.52 133644 5
View Market Depth
Last trade - 16.10pm 12/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.